Exploring the Potential of Probiotics and Gut Microbiota Modulation in the Management of Rheumatoid Arthritis: A Review of Current Mechanisms and Therapeutic Strategies

Authors

Abstract

Summary: Background: Rheumatoid arthritis (RA) is a persistent autoimmune disorder that attacks the joints, resulting in inflammation and potential joint deterioration over time. This disease impacts roughly 1% of the global population, occurs more frequently in women, and arises from both inherited and environmental factors.

Main Body: Even though disease-modifying antirheumatic drugs (DMARDs) and nonsteroidal anti-inflammatory drugs (NSAIDs) are widely available, their effectiveness is often hampered by side effects, toxicity concerns, and high costs. Researchers are increasingly focusing on the pre-clinical phase of rheumatoid arthritis (RA) as a key opportunity for intervention. Growing evidence underscores the gut microbiome's pivotal influence on RA's onset. An imbalance in gut bacteria—known as dysbiosis—appears to trigger autoimmunity in conditions like RA, possibly via molecular mimicry and other pathways that fuel immune overreactions.

Probiotics, especially strains from Lactobacillus and Bifidobacterium, offer hope by restoring gut balance, dialing down inflammation, and easing RA symptoms. Both animal models and human trials back this up, showing drops in inflammatory markers like pro-inflammatory cytokines and C-reactive protein (CRP), alongside real-world relief from issues such as swollen joints and pain.

Conclusion: This review explores how gut microbes contribute to the development of rheumatoid arthritis (RA) and highlights the encouraging potential of probiotics for easing RA symptoms. On top of that, dietary strategies—like the Mediterranean diet, which can reshape the gut microbiome—hold promise for better RA control by curbing inflammation and boosting overall disease outcomes.

Keywords: Rheumatoid arthritis, gut microbiota, probiotics, Lactobacillus, Bifidobacterium

Keywords:

Rheumatoid arthritis, Gut Microbiota, Probiotics, Lactobacillus, Bifidobacterium

DOI

https://doi.org/10.22270/jddt.v16i3.7639

Author Biographies

Snehal Ambadas Gojare , Department of Pharmacology, Progressive Education Society’s Modern college of Pharmacy, Nigdi, Pune-044.

Department of Pharmacology, Progressive Education Society’s Modern college of Pharmacy, Nigdi, Pune-044.

Pranoti Aher , Department of Pharmacology, Progressive Education Society’s Modern college of Pharmacy, Nigdi, Pune-044.

Department of Pharmacology, Progressive Education Society’s Modern college of Pharmacy, Nigdi, Pune-044.

Rachana Lokhande , Department of Pharmacology, Progressive Education Society’s Modern college of Pharmacy, Nigdi, Pune-044.

Department of Pharmacology, Progressive Education Society’s Modern college of Pharmacy, Nigdi, Pune-044.

Nikita Game, Department of Pharmacology, Progressive Education Society’s Modern college of Pharmacy, Nigdi, Pune-044.

Department of Pharmacology, Progressive Education Society’s Modern college of Pharmacy, Nigdi, Pune-044.

Priyanka Nanasaheb Khamkar , Department of Pharmacology, Progressive Education Society’s Modern college of Pharmacy, Nigdi, Pune-044.

Department of Pharmacology, Progressive Education Society’s Modern college of Pharmacy, Nigdi, Pune-044.

References

1. Swathi KP, Jayaram S, Sugumar D, Rymbai E. Evaluation of anti-inflammatory and anti-arthritic property of ethanolic extract of Clitoriaternatea. Chinese herbal medicines. 2021 Apr 1;13(2):243-9. https://doi.org/10.1016/j.chmed.2020.11.004 PMid:36117501 PMCid:PMC9476680

2. Deshmukh R. Rheumatoid arthritis: Pathophysiology, current therapeutic strategies and recent advances in targeted drug delivery system. Materials Today Communications. 2023 Jun 1; 35:105877. https://doi.org/10.1016/j.mtcomm.2023.105877

3. Kochi Y, Suzuki A, Yamamoto K. Genetic basis of rheumatoid arthritis: a current review. Biochemical and biophysical research communications. 2014 Sep 19;452(2):254-62. https://doi.org/10.1016/j.bbrc.2014.07.085 PMid:25078624

4. Wang YZ, Sun SQ, Zhou YB. Extract of the dried heartwood of Caesalpiniasappan L. attenuates collagen-induced arthritis. Journal of ethnopharmacology. 2011 Jun 14;136(1):271-8. https://doi.org/10.1016/j.jep.2011.04.061 PMid:21557995

5. Shen X, Li C, Zhao H, Li S, Chen J, Kobayashi Y, Shen W. Inhibitory effects of a traditional Chinese herbal formula TBL-II on type II collagen-induced arthritis in mice. Journal of ethnopharmacology. 2011 Mar 24;134(2):399-405. https://doi.org/10.1016/j.jep.2010.12.033 PMid:21215307

6. Raza K, Klareskog L, Holers VM. Predicting and preventing the development of rheumatoid arthritis. Rheumatology. 2016 Jan 1;55(1):1-3. https://doi.org/10.1093/rheumatology/kev261 PMid:26224307 PMCid:PMC5854029

7. Gerlag DM, Raza K, Van Baarsen LG, Brouwer E, Buckley CD, Burmester GR, et al.EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis. Annals of the rheumatic diseases. 2012 May 1;71(5):638-41. https://doi.org/10.1136/annrheumdis-2011-200990 PMid:22387728 PMCid:PMC3329228

8. Rooney CM, Mankia K, Mitra S, Moura IB, Emery P, Wilcox MH. Perturbations of the gut microbiome in anti-CCP positive individuals at risk of developing rheumatoid arthritis. Rheumatology. 2021 Jul 1;60(7):3380-7. https://doi.org/10.1093/rheumatology/keaa792 PMid:33313854

9. Jubair WK, Hendrickson JD, Severs EL, Schulz HM, Adhikari S, Ir D, et al. Modulation of inflammatory arthritis in mice by gut microbiota through mucosal inflammation and autoantibody generation. Arthritis & rheumatology. 2018 Aug;70(8):1220-33. https://doi.org/10.1002/art.40490 PMid:29534332 PMCid:PMC6105374

10. Chen B, Sun L, Zhang X. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases. Journal of autoimmunity. 2017 Sep 1; 83:31-42. https://doi.org/10.1016/j.jaut.2017.03.009 PMid:28342734

11. Rooney CM, Mankia K, Emery P. The role of the microbiome in driving RA-related autoimmunity. Frontiers in cell and developmental biology. 2020 Sep 29; 8:538130. https://doi.org/10.3389/fcell.2020.538130 PMid:33134291 PMCid:PMC7550627

12. Balasundaram D, Veerasamy V, Singarayar MS, Neethirajan V, Devanesan AA, Thilagar S. Therapeutic potential of probiotics in gut microbial homeostasis and Rheumatoid arthritis. International Immunopharmacology. 2024 Aug 20; 137:112501. https://doi.org/10.1016/j.intimp.2024.112501 PMid:38885604

13. Mohammed AT, Khattab M, Ahmed AM, Turk T, Sakr N, M. Khalil A, et al. The therapeutic effect of probiotics on rheumatoid arthritis: a systematic review and meta-analysis of randomized control trials. Clinical rheumatology. 2017 Dec; 36:2697-707. https://doi.org/10.1007/s10067-017-3814-3 PMid:28914373

14. Bedaiwi MK, Inman RD. Microbiome and probiotics: link to arthritis. Current opinion in rheumatology. 2014 Jul 1;26(4):410-5. https://doi.org/10.1097/BOR.0000000000000075 PMid:24841227

15. Kim JE, Chae CS, Kim GC, Hwang W, Hwang JS, Hwang SM, et al. Lactobacillus helveticus suppresses experimental rheumatoid arthritis by reducing inflammatory T cell responses. journal of functional foods. 2015 Mar 1; 13:350-62. https://doi.org/10.1016/j.jff.2015.01.002

16. Bungau SG, Behl T, Singh A, Sehgal A, Singh S, Chigurupati S, et al. Targeting probiotics in rheumatoid arthritis. Nutrients. 2021 Sep 26;13(10):3376. https://doi.org/10.3390/nu13103376 PMid:34684377 PMCid:PMC8539185

17. Liam J. O'Neil, DeshiréAlpízar-Rodríguez, Kevin D. Deane The Journal of Rheumatology Jan 2024, jrheum.2023-0334; DOI: 10.3899/jrheum.2023-0334 https://doi.org/10.3899/jrheum.2023-0334 PMid:38224993 PMCid:PMC10984790

18. Wang P, Tao JH, Pan HF. Probiotic bacteria: a viable adjuvant therapy for relieving symptoms of rheumatoid arthritis. Inflammopharmacology. 2016 Oct; 24:189-96. https://doi.org/10.1007/s10787-016-0277-0 PMid:27581587

19. Ferro M, Charneca S, Dourado E, Guerreiro CS, Fonseca JE. Probiotic supplementation for rheumatoid arthritis: A promising adjuvant therapy in the gut microbiome era. Frontiers in Pharmacology. 2021 Jul 23; 12:711788. https://doi.org/10.3389/fphar.2021.711788 PMid:34366867 PMCid:PMC8346200

20. Amdekar S, Singh V, Singh R, Sharma P, Keshav P, Kumar A. Lactobacillus casei reduces the inflammatory joint damage associated with collagen-induced arthritis (CIA) by reducing the pro-inflammatory cytokines: Lactobacillus casei: COX-2 inhibitor. Journal of clinical immunology. 2011 Apr; 31:147-54. https://doi.org/10.1007/s10875-010-9457-7 PMid:20838859

21. Pan H, Guo R, Ju Y, Wang Q, Zhu J, Xie Y, et al. A single bacterium restores the microbiome dysbiosis to protect bones from destruction in a rat model of rheumatoid arthritis. Microbiome. 2019 DSo JS, Lee CG, Kwon HK, Yi HJ, Chae CS, Park JA, et al. Lactobacillus casei potentiates induction of oral tolerance in experimental arthritis. Molecular immunology. 2008 Nov 1;46(1):172-80.ec;7:1-1. https://doi.org/10.1186/s40168-019-0719-1 PMid:31315667 PMCid:PMC6637628

22. So JS, Lee CG, Kwon HK, Yi HJ, Chae CS, Park JA, et al. Lactobacillus casei potentiates induction of oral tolerance in experimental arthritis. Molecular immunology. 2008 Nov 1;46(1):172-80. https://doi.org/10.1016/j.molimm.2008.07.038 PMid:18804867

23. Gohil P, Patel V, Deshpande S, Chorawala M, Shah G. Anti-arthritic activity of cell walls content of Lactobacillus plantarum in freund's adjuvant-induced arthritic rats: involvement of cellular inflammatory mediators and other biomarkers. Inflammopharmacology. 2018 Feb; 26:171-81. https://doi.org/10.1007/s10787-017-0370-z PMid:28685302

24. Vaghef-Mehrabany E, Homayouni-Rad A, Alipour B, Sharif SK, Vaghef-Mehrabany L, Alipour-Ajiry S. Effects of probiotic supplementation on oxidative stress indices in women with rheumatoid arthritis: a randomized double-blind clinical trial. Journal of the American College of Nutrition. 2016 May 18;35(4):291-9. https://doi.org/10.1080/07315724.2014.959208 PMid:25856220

25. Alipour B, Homayouni‐Rad A, Vaghef‐Mehrabany E, Sharif SK, Vaghef‐Mehrabany L, Asghari‐Jafarabadi M, et al. Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double‐blind clinical trial. International journal of rheumatic diseases. 2014 Jun;17(5):519-27. https://doi.org/10.1111/1756-185X.12333 PMid:24673738

26. Hatakka K, Martio J, Korpela M, Herranen M, Poussa T, Laasanen T, et al. Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis-a pilot study. Scandinavian journal of rheumatology. 2003 Aug 1;32(4):211-5. https://doi.org/10.1080/03009740310003695 PMid:14626627

27. Zamani B, Farshbaf S, Golkar HR, Bahmani F, Asemi Z. Synbiotic supplementation and the effects on clinical and metabolic responses in patients with rheumatoid arthritis: a randomised, double-blind, placebo-controlled trial. British journal of nutrition. 2017 Apr;117(8):1095-102. https://doi.org/10.1017/S000711451700085X PMid:28490394

28. Cannarella LA, Mari NL, Alcântara CC, Iryioda TM, Costa NT, Oliveira SR, et al. Mixture of probiotics reduces inflammatory biomarkers and improves the oxidative/nitrosative profile in people with rheumatoid arthritis. Nutrition. 2021 Sep 1; 89:111282. https://doi.org/10.1016/j.nut.2021.111282 PMid:34111674

29. Ermencheva P, Kotov G, Shumnalieva R, Velikova T, Monov S. Exploring the Role of the Microbiome in Rheumatoid Arthritis-A Critical Review. Microorganisms. 2024 Jul;12(7):1387. https://doi.org/10.3390/microorganisms12071387 PMid:39065155 PMCid:PMC11278530

30. Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays. 2003 Nov;25(11):1106-18. https://doi.org/10.1002/bies.10357 PMid:14579251

31. Smit MD, Westra J, Vissink A, Doornbos-van der Meer B, Brouwer E, van Winkelhoff AJ. Periodontitis in established rheumatoid arthritis patients: a cross-sectional clinical, microbiological and serological study. Arthritis research & therapy. 2012 Oct; 14:1-0. https://doi.org/10.1186/ar4061 PMid:23075462 PMCid:PMC3580533

32. Quirke AM, Lugli EB, Wegner N, Hamilton BC, Charles P, Chowdhury M, Ytterberg AJ, et al. Heightened immune response to autocitrullinatedPorphyromonasgingivalispeptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis. Annals of the rheumatic diseases. 2014 Jan 1;73(1):263-9. https://doi.org/10.1136/annrheumdis-2012-202726 PMid:23463691 PMCid:PMC3888615

33. Liu X, Zeng B, Zhang J, Li W, Mou F, Wang H, Zou Q, et al. Role of the gut microbiome in modulating arthritis progression in mice. Scientific reports. 2016 Aug 2;6(1):30594. https://doi.org/10.1038/srep30594 PMid:27481047 PMCid:PMC4969881

34. Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nature medicine. 2015 Aug;21(8):895-905. https://doi.org/10.1038/nm.3914 PMid:26214836

35. Maeda Y, Kurakawa T, Umemoto E, Motooka D, Ito Y, Gotoh K, et al. Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine. Arthritis & rheumatology. 2016 Nov;68(11):2646-61. https://doi.org/10.1002/art.39783 PMid:27333153

36. Konig MF, Abusleme L, Reinholdt J, Palmer RJ, Teles RP, Sampson K, et al. Aggregatibacteractinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Science translational medicine. 2016 Dec 14;8(369):369ra176. https://doi.org/10.1126/scitranslmed.aaj1921 PMCid:PMC5384717

37. Scher JU, Ubeda C, Equinda M, Khanin R, Buischi Y, Viale A, et al. Periodontal disease and the oral microbiota in new‐onset rheumatoid arthritis. Arthritis & Rheumatism. 2012 Oct;64(10):3083-94. https://doi.org/10.1002/art.34539 PMid:22576262 PMCid:PMC3428472

38. Lopez‐Oliva I, Paropkari AD, Saraswat S, Serban S, Yonel Z, Sharma P, et al. Dysbioticsubgingival microbial communities in periodontally healthy patients with rheumatoid arthritis. Arthritis & Rheumatology. 2018 Jul;70(7):1008-13. https://doi.org/10.1002/art.40485 PMid:29513935 PMCid:PMC6019644

39. Giachetto PF, Cunha RC, Nhani Jr A, Garcia MV, Ferro JA, Andreotti R. Gene expression in the salivary gland of Rhipicephalus (Boophilus) microplus fed on tick-susceptible and tick-resistant hosts. Frontiers in Cellular and Infection Microbiology. 2020 Jan 21; 9:477. https://doi.org/10.3389/fcimb.2019.00477 PMid:32039052 PMCid:PMC6985549

40. Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T, Zeevi D, et al. Environment dominates over host genetics in shaping human gut microbiota. Nature. 2018 Mar;555(7695):210-5. https://doi.org/10.1038/nature25973 PMid:29489753

41. Kolodziejczyk AA, Zheng D, Elinav E. Diet-microbiota interactions and personalized nutrition. Nature Reviews Microbiology. 2019 Dec;17(12):742-53. https://doi.org/10.1038/s41579-019-0256-8 PMid:31541197

42. Petersson S, Philippou E, Rodomar C, Nikiphorou E. The Mediterranean diet, fish oil supplements and Rheumatoid arthritis outcomes: Evidence from clinical trials. Autoimmunity reviews. 2018 Nov 1;17(11):1105-14. https://doi.org/10.1016/j.autrev.2018.06.007 PMid:30213690

43. Watson JE, Kim JS, Das A. Emerging class of omega-3 fatty acid endocannabinoids & their derivatives. Prostaglandins & other lipid mediators. 2019 Aug 1; 143:106337. https://doi.org/10.1016/j.prostaglandins.2019.106337 PMid:31085370 PMCid:PMC6685292

44. Chasov, V., Gilyazova, E., Ganeeva, I., Zmievskaya, E., Davletshin, D., Valiullina, A., &Bulatov, E. (2024). Gut Microbiota Modulation: A Novel Strategy for Rheumatoid Arthritis Therapy. Biomolecules, 14(12), 1653. https://doi.org/10.3390/biom14121653 PMid:39766360 PMCid:PMC11674688

45. Gioxari A, Kaliora AC, Marantidou F, Panagiotakos DP. Intake of ω-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: A systematic review and meta-analysis. Nutrition. 2018 Jan 1; 45:114-24. https://doi.org/10.1016/j.nut.2017.06.023 PMid:28965775

46. Jiang J, Li K, Wang F, Yang B, Fu Y, Zheng J, et al. Effect of marine-derived n-3 polyunsaturated fatty acids on major eicosanoids: a systematic review and meta-analysis from 18 randomized controlled trials. PloS one. 2016 Jan 25;11(1): e0147351. https://doi.org/10.1371/journal.pone.0147351 PMid:26808318 PMCid:PMC4726565

47. Hoxha M. A systematic review on the role of eicosanoid pathways in rheumatoid arthritis. Advances in medical sciences. 2018 Mar 1;63(1):22-9. https://doi.org/10.1016/j.advms.2017.06.004 PMid:28818745

48. Lee YH, Bae SC, Song GG. Omega-3 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a meta-analysis. Archives of medical research. 2012 Jul 1;43(5):356-62. https://doi.org/10.1016/j.arcmed.2012.06.011 PMid:22835600

49. Abdulrazaq M, Innes JK, Calder PC. Effect of ω-3 polyunsaturated fatty acids on arthritic pain: A systematic review. Nutrition. 2017 Jul 1; 39:57-66. https://doi.org/10.1016/j.nut.2016.12.003 PMid:28606571

50. Berbert AA, Kondo CR, Almendra CL, Matsuo T, Dichi I. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis. Nutrition. 2005 Feb 1;21(2):131-6. https://doi.org/10.1016/j.nut.2004.03.023 PMid:15723739

51. Conaghan PG, Hensor EM, Keenan AM, Morgan AW, Emery P, YEAR Consortium. Persistently moderate DAS-28 is not benign: loss of function occurs in early RA despite step-up DMARD therapy. Rheumatology. 2010 Oct 1;49(10):1894-9. https://doi.org/10.1093/rheumatology/keq178 PMid:20542894

52. McKellar G, Morrison E, McEntegart A, Hampson R, Tierney A, Mackle G, et al. A pilot study of a Mediterranean-type diet intervention in female patients with rheumatoid arthritis living in areas of social deprivation in Glasgow. Annals of the rheumatic diseases. 2007 Sep 1;66(9):1239-43. https://doi.org/10.1136/ard.2006.065151 PMid:17613557 PMCid:PMC1955146

53. Sköldstam L, Hagfors L, Johansson G. An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis. Annals of the rheumatic diseases. 2003 Mar 1;62(3):208-14. https://doi.org/10.1136/ard.62.3.208 PMid:12594104 PMCid:PMC1754463

Published

2026-03-15
Statistics
Abstract Display: 177
PDF Downloads: 122
PDF Downloads: 25

How to Cite

1.
Gojare SA, Aher P, Lokhande R, Game N, Khamkar PN. Exploring the Potential of Probiotics and Gut Microbiota Modulation in the Management of Rheumatoid Arthritis: A Review of Current Mechanisms and Therapeutic Strategies. J. Drug Delivery Ther. [Internet]. 2026 Mar. 15 [cited 2026 Apr. 18];16(3):366-73. Available from: https://www.jddtonline.info/index.php/jddt/article/view/7639

How to Cite

1.
Gojare SA, Aher P, Lokhande R, Game N, Khamkar PN. Exploring the Potential of Probiotics and Gut Microbiota Modulation in the Management of Rheumatoid Arthritis: A Review of Current Mechanisms and Therapeutic Strategies. J. Drug Delivery Ther. [Internet]. 2026 Mar. 15 [cited 2026 Apr. 18];16(3):366-73. Available from: https://www.jddtonline.info/index.php/jddt/article/view/7639